Skip to main content
Premium Trial:

Request an Annual Quote

OptraHealth, InformedDNA Partner for Remote Genetic Counseling

NEW YORK – OptraHealth said today that it is partnering with InformedDNA to make the latter's network of genetic counselors remotely available to users of the OptraHealth GeneFax system.

As a result of the telegenetics partnership consumers on the GeneFax Counselor Connect scheduling platform will be able to reach InformedDNA counselors online to ask questions about genetic and prenatal testing, enhancing the artificial intelligence-driven GeneFax chatbot model offered by San Jose, California-based OptraHealth.

Notably, the GeneFax system allows consumers and healthcare providers to query genetic data via a chatbot, mobile application, and voice assistants like Amazon's Alexa, Microsoft's Cortana, and Google Home. 

"I strongly believe that the combination of GeneFax's AI technology and expert genetic counseling services of InformedDNA will extend the reach of genetic testing and engage users meaningfully," OptraHealth Founder and CEO Gauri Naik said in a statement. "It will also empower users to get more out of genetic testing in order to take control of their health."

"Partnering with OptraHealth opens yet another avenue to help patients, providers, labs, and payors better understand the genetic landscape, including testing and treatment considerations," Amber Trived, chief innovation officer of St. Petersburg, Florida-based InformedDNA, said. "Now, these audiences will have even more resources at their fingertips to help navigate the complexities related to genetic testing."

InformedDNA already provides counseling and management services to the likes of Coriell Institute for Medical Research, WIRB-Copernicus Group, and AIM Specialty Health to support drug development for precision medicine and to help payors manage appropriate genetic testing utilization.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.